Thursday, November 5, 2015
According to a 2015 market research report, the global clinical development outsourcing market will top $64 billion by 2020, with CROs managing nearly 72% of all clinical trials. As the outsourced model grows, sponsor-vendor relationships will play a much larger role in trial success.
Global CRO Quintiles and IMS Health, a global information and technology services company, have announced a global strategic alliance that will advance the way biopharmaceutical companies generate real-world evidence (RWE) and apply critical insights to drive late-stage clinical research. Offering complementary strengths in real-world data management, operational delivery, advanced analytics and scientific and therapeutic expertise, the collaboration is designed to accelerate assessments of treatment impact and help improve patient outcomes.
BioClinica, a Pennsylvania-based specialty clinical trials technology services provider, has announced the roll out of a new eClinical CRO Partner Alliance program, accelerating adoption of industry-leading eHealth solutions by CROs. The decision to redesign the CRO partner channel comes in response to growing demand for a premier eClinical technology platform that enables CROs and sponsors to conduct studies in an efficient and accelerated manner.
Kevin Gordon, who is serving as executive vice president of operations and chief financial officer at Quintiles, a North Carolina-based CRO, has been promoted to chief operating officer at the company. In addition, Michael McDonnell is expected to join Quintiles in December as EVP and CFO.
CluePoints, a Cambridge, Mass.-based software provider of risk-based monitoring (RBM) solutions for clinical trials, has partnered with Bracket Global, a provider of technologies and services that drive superior clinical outcome results. The exclusive partnership will see CluePoints’ RBM software offered in combination with Bracket’s Blinded Data Analytics and Rater Training and Quality Assurance oversight program for psychiatry and neurology trials. Bringing together CluePoints’ and Bracket’s solutions will enhance the impact of the services that each company delivers to sponsors, improving the integrity and quality of clinical data.
Aesica, a U.K.-based global pharmaceutical contract development and manufacturing organization (CDMO), has unveiled a new approach and business model that solves multiple supply-chain challenges at once. The company takes on the management of other CDMOs, while serving as the single, central point of customer contact.